Intellia Therapeutics Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street futures fall as oil, Treasury yields rise on Iran tensions
- Oil prices fall after hitting over one-month high; traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Intellia Therapeutics (NTLA) PT Raised to $42 at Jefferies
November 1, 2017 7:48 AM EDTJefferies raised its price target on Intellia Therapeutics (NASDAQ: NTLA) to $42.00 (from $36.00) while maintaining a Buy rating.
... MoreIntellia Therapeutics (NTLA) PT Raised to $36 at Wedbush
November 1, 2017 7:26 AM EDTWedbush raised its price target on Intellia Therapeutics (NASDAQ: NTLA) to $36.00 (from $29.00) while maintaining a Outperform rating.
... More